HomeInterrad Medical, Inc.

Interrad Medical, Inc.

SecurAcath Study of Over 2000 Patients Shows Major Cost Savings Compared to Adhesives

The study was published in the Journal of Vascular Access in June 2019.

New Clinical Data Shows Decreased Catheter-Related Infection Risk with Use of SecurAcath

9/26/18: “We are very excited this new data supports the fact that the improved stability and site cleaning SecurAcath provides results in reduced catheter-related infections,” commented Joe Goldberger, President and CEO of Interrad Medical.